Xifaxan (Rifaximin) - Summary

XIFAXAN SUMMARY

XIFAXAN^™ (rifaximin) Tablets
(zuh FAX in)

XIFAXAN™ Tablets contain rifaximin, a semi-synthetic, non-systemic antibiotic.

XIFAXAN™ Tablets are indicated for the treatment of patients (>/=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli (see WARNINGS, Microbiology, and CLINICAL STUDIES).

XIFAXAN™ Tablets should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than Escherichia coli.

XIFAXAN NEWS HIGHLIGHTS

Media Articles Related to Xifaxan (Rifaximin)

Salix Presents New Phase II Data Evidence Demonstrating The Clinical Utility Of Rifaximin In Irritable Bowel Syndrome (IBS)
Source: Health News from Medical News Today [2008.10.06]

Salix Initiates Phase 3 For Rifaximin In Non-Constipation Irritable Bowel Syndrome
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.07.03]

more>>

Published Studies Related to Xifaxan (Rifaximin)

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. [2008.06.23]

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. [2007.10]

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study. [2007.06.13]

The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. [2006.10.17]

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. [2006.06]

more>>

Clinical Trials Related to Xifaxan (Rifaximin)

Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome [Completed]

Induction of Clinical Response Using Rifaximin in Crohn's Disease [Not yet recruiting]

Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease [Recruiting]

RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial [Recruiting]

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) [Recruiting]

more>>